Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Apr-24 4:15 PM View:  | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 01-Apr-24 | Planned Option Sale | 50,000 | $42.33 | $2,116,640.00 | (76%) 65.64K to 15.64K | |
| 03-Apr-24 4:15 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 01-Apr-24 | Option Exercise | 50,000 | $3.50 | $175,000.00 | 320% 15.64K to 65.64K | |
| 06-Mar-24 4:15 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 04-Mar-24 | Option Exercise | 50,000 | $3.50 | $175,000.00 | 320% 15.64K to 65.64K | |
| 06-Mar-24 4:15 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 04-Mar-24 | Planned Option Sale | 50,000 | $41.01 | $2,050,550.00 | (76%) 65.64K to 15.64K | |
| 04-Mar-24 5:49 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 29-Feb-24 | Option Exercise | 50,000 | $3.50 | $175,000.00 | 320% 15.64K to 65.64K | |
| 04-Mar-24 5:49 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 29-Feb-24 | Planned Option Sale | 50,000 | $41.16 | $2,057,890.00 | (76%) 65.64K to 15.64K | |
| 21-Feb-24 4:54 PM View: | Perceptive Advisors LLC Director | Cerevel Therapeutics Holdin... (CERE) | 20-Feb-24 | Gift | 170,317 | -- | -- | (2%) 10.97M to 10.79M | |
| 08-Feb-24 7:19 PM View: | Renger John Chief Scientific Officer | Cerevel Therapeutics Holdin... (CERE) | 07-Feb-24 | Option Sale | 2,161 | $41.54 | $89,776.80 | (25%) 8.53K to 6.37K | |
| 08-Feb-24 7:14 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 07-Feb-24 | Option Sale | 2,506 | $41.54 | $104,110.00 | (14%) 18.14K to 15.64K | |
| 08-Feb-24 7:14 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 06-Feb-24 | Option Exercise | 15,440 | -- | -- | 571% 2.7K to 18.14K | |
| 08-Feb-24 7:19 PM View: | Renger John Chief Scientific Officer | Cerevel Therapeutics Holdin... (CERE) | 06-Feb-24 | Option Exercise | 5,020 | -- | -- | 143% 3.51K to 8.53K | |
| 04-Jan-24 4:15 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 02-Jan-24 | Option Exercise | 50,000 | $3.50 | $175,000.00 | 1849% 2.7K to 52.7K | |
| 04-Jan-24 4:15 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 02-Jan-24 | Planned Option Sale | 50,000 | $42.24 | $2,111,820.00 | (95%) 52.7K to 2.7K | |
| 28-Dec-23 4:15 PM View: | Sanchez Ramiro Chief Medical Officer | Cerevel Therapeutics Holdin... (CERE) | 26-Dec-23 | Option Exercise | 10,000 | $3.50 | $35,000.00 | 68% 14.67K to 24.67K | |
| 28-Dec-23 4:15 PM View: | Tregoning Kathleen See Remarks | Cerevel Therapeutics Holdin... (CERE) | 26-Dec-23 | Option Exercise | 3,150 | $10.05 | $31,657.50 | 42% 7.52K to 10.67K | |
| 28-Dec-23 4:15 PM View: | Sanchez Ramiro Chief Medical Officer | Cerevel Therapeutics Holdin... (CERE) | 26-Dec-23 | Planned Option Sale | 10,000 | $42.47 | $424,700.00 | (41%) 24.67K to 14.67K | |
| 27-Dec-23 4:15 PM View: | Dipietro Kenneth Chief Human Resources Officer | Cerevel Therapeutics Holdin... (CERE) | 22-Dec-23 | Option Sale | 8,000 | $41.45 | $331,608.00 | (24%) 32.66K to 24.66K | |
| 27-Dec-23 4:15 PM View: | Dipietro Kenneth Chief Human Resources Officer | Cerevel Therapeutics Holdin... (CERE) | 22-Dec-23 | Option Exercise | 8,000 | $3.50 | $28,000.00 | 32% 24.66K to 32.66K | |
| 21-Dec-23 8:10 PM View: | Tregoning Kathleen See Remarks | Cerevel Therapeutics Holdin... (CERE) | 20-Dec-23 | Option Sale | 6,288 | $41.42 | $260,469.00 | (46%) 13.8K to 7.52K | |
| 21-Dec-23 8:27 PM View: | Bodenrader Mark See Remarks | Cerevel Therapeutics Holdin... (CERE) | 20-Dec-23 | Option Sale | 7,889 | $41.42 | $326,788.00 | (31%) 25.61K to 17.72K | |
| 21-Dec-23 8:12 PM View: | Altschuller Susan Chief Financial Officer | Cerevel Therapeutics Holdin... (CERE) | 20-Dec-23 | Option Sale | 13,808 | $41.42 | $571,972.00 | (45%) 30.72K to 16.91K | |
| 21-Dec-23 8:14 PM View: | Sanchez Ramiro Chief Medical Officer | Cerevel Therapeutics Holdin... (CERE) | 20-Dec-23 | Option Sale | 10,152 | $41.42 | $420,528.00 | (41%) 24.82K to 14.67K | |
| 21-Dec-23 8:24 PM View: | Dipietro Kenneth Chief Human Resources Officer | Cerevel Therapeutics Holdin... (CERE) | 20-Dec-23 | Option Sale | 6,256 | $41.42 | $259,144.00 | (20%) 30.92K to 24.66K | |
| 21-Dec-23 8:21 PM View: | Akamine Scott Chief Legal Officer | Cerevel Therapeutics Holdin... (CERE) | 20-Dec-23 | Option Sale | 7,072 | $41.42 | $292,945.00 | (49%) 14.31K to 7.24K | |
| 21-Dec-23 8:27 PM View: | Bodenrader Mark See Remarks | Cerevel Therapeutics Holdin... (CERE) | 19-Dec-23 | Option Exercise | 19,284 | -- | -- | 305% 6.33K to 25.61K | |
| 21-Dec-23 8:12 PM View: | Altschuller Susan Chief Financial Officer | Cerevel Therapeutics Holdin... (CERE) | 19-Dec-23 | Option Exercise | 30,721 | -- | -- | 100% 0 to 30.72K | |
| 21-Dec-23 8:18 PM View: | Renaud Ronald C Jr President & CEO Director | Cerevel Therapeutics Holdin... (CERE) | 19-Dec-23 | Option Exercise | 160,452 | -- | -- | 191% 83.86K to 244.31K | |
| 21-Dec-23 8:24 PM View: | Dipietro Kenneth Chief Human Resources Officer | Cerevel Therapeutics Holdin... (CERE) | 19-Dec-23 | Option Exercise | 13,913 | -- | -- | 82% 17.01K to 30.92K | |
| 21-Dec-23 8:14 PM View: | Sanchez Ramiro Chief Medical Officer | Cerevel Therapeutics Holdin... (CERE) | 19-Dec-23 | Option Exercise | 24,825 | -- | -- | 100% 0 to 24.82K | |
| 21-Dec-23 8:10 PM View: | Tregoning Kathleen See Remarks | Cerevel Therapeutics Holdin... (CERE) | 19-Dec-23 | Option Exercise | 13,804 | -- | -- | 100% 0 to 13.8K | |
| 21-Dec-23 8:26 PM View: | Burgess Paul D. See Remarks | Cerevel Therapeutics Holdin... (CERE) | 19-Dec-23 | Option Exercise | 23,847 | -- | -- | 109% 21.88K to 45.73K | |
| 21-Dec-23 8:21 PM View: | Akamine Scott Chief Legal Officer | Cerevel Therapeutics Holdin... (CERE) | 19-Dec-23 | Option Exercise | 13,796 | -- | -- | 2689% 0.51K to 14.31K | |
| 19-Dec-23 4:15 PM View: | Sanchez Ramiro Chief Medical Officer | Cerevel Therapeutics Holdin... (CERE) | 15-Dec-23 | Option Sale | 7,500 | $41.39 | $310,393.00 | (100%) 7.5K to 0 | |
| 19-Dec-23 4:15 PM View: | Sanchez Ramiro Chief Medical Officer | Cerevel Therapeutics Holdin... (CERE) | 15-Dec-23 | Option Exercise | 7,500 | $9.88 | $74,100.00 | 100% 0 to 7.5K | |
| 11-Dec-23 4:17 PM View: | Sanchez Ramiro Chief Medical Officer | Cerevel Therapeutics Holdin... (CERE) | 07-Dec-23 | Option Exercise | 10,000 | $3.50 | $35,000.00 | 100% 0 to 10.0K | |
| 07-Dec-23 7:45 PM View: | Akamine Scott Chief Legal Officer | Cerevel Therapeutics Holdin... (CERE) | 07-Dec-23 | Option Exercise | 10,000 | $13.17 | $131,700.00 | 1949% 0.51K to 10.51K | |
| 07-Dec-23 7:45 PM View: | Akamine Scott Chief Legal Officer | Cerevel Therapeutics Holdin... (CERE) | 07-Dec-23 | Planned Option Sale | 10,000 | $41.37 | $413,700.00 | (95%) 10.51K to 0.51K | |
| 11-Dec-23 4:17 PM View: | Sanchez Ramiro Chief Medical Officer | Cerevel Therapeutics Holdin... (CERE) | 07-Dec-23 | Planned Option Sale | 10,000 | $41.37 | $413,700.00 | (100%) 10.0K to 0 | |
| 07-Dec-23 7:45 PM View: | Akamine Scott Chief Legal Officer | Cerevel Therapeutics Holdin... (CERE) | 05-Dec-23 | Option Exercise | 7,500 | $13.17 | $98,775.00 | 1462% 0.51K to 8.01K | |
| 07-Dec-23 7:45 PM View: | Akamine Scott Chief Legal Officer | Cerevel Therapeutics Holdin... (CERE) | 05-Dec-23 | Planned Option Sale | 7,500 | $35.00 | $262,500.00 | (94%) 8.01K to 0.51K | |
| 16-Nov-23 4:15 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 14-Nov-23 | Option Exercise | 22,824 | $3.50 | $79,884.00 | 844% 2.7K to 25.53K | |
| 16-Nov-23 4:15 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 14-Nov-23 | Planned Option Sale | 22,824 | $25.13 | $573,455.00 | (89%) 25.53K to 2.7K | |
| 09-Nov-23 5:03 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 08-Nov-23 | Option Exercise | 100 | $3.50 | $350.00 | 4% 2.7K to 2.8K | |
| 09-Nov-23 5:03 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 08-Nov-23 | Planned Option Sale | 100 | $25.16 | $2,516.00 | (4%) 2.8K to 2.7K | |
| 09-Nov-23 5:03 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 07-Nov-23 | Option Exercise | 27,076 | $3.50 | $94,766.00 | 1001% 2.7K to 29.78K | |
| 09-Nov-23 5:03 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 07-Nov-23 | Planned Option Sale | 27,076 | $25.02 | $677,555.00 | (91%) 29.78K to 2.7K | |
| 06-Nov-23 5:12 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 03-Nov-23 | Option Exercise | 61,401 | $3.50 | $214,904.00 | 2271% 2.7K to 64.11K | |
| 06-Nov-23 5:12 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 03-Nov-23 | Planned Option Sale | 61,401 | $25.43 | $1,561,460.00 | (96%) 64.11K to 2.7K | |
| 06-Nov-23 5:12 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 02-Nov-23 | Option Exercise | 38,599 | $3.50 | $135,096.00 | 1427% 2.7K to 41.3K | |
| 06-Nov-23 5:12 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 02-Nov-23 | Planned Option Sale | 38,599 | $25.19 | $972,239.00 | (93%) 41.3K to 2.7K |
